RSS   Newsletter   Contact   Advertise with us
Post Online Media

Repros announces new CEO

ReprosRepros Therapeutics Inc., a development stage biopharmaceutical company, announced that Joseph S. Podolski is leaving his position as president and CEO and member of the board of directors.
Larry Dillaha, Chief Executive Officer of CavtheRx, was appointed interim President and Chief Executive Officer of the Company.

Prior to becoming CEO of CavtheRx, Dr. Dillaha was Chief Operating Officer and Chief Medical Officer of New Haven Pharmaceuticals, a specialty pharmaceutical company.

Dr. Dillaha also served as Chief Medical Officer of Insys Therapeutics, Sciele Pharma and as Medical Director of Sanofi-Sythelabo.

He received an M.D. degree from the University of Tennessee, Memphis.




We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy